For Your Information
FTC Approves Final Order Imposing Conditions on Stryker Corp.’s Acquisition of Wright Medical Group N.V.
Following a public comment period, the Â鶹´«Ã½ Trade Commission has approved a final orderÌýsettling charges that medical device company Stryker Corp.’s proposed $4 billion acquisition of competitor Wright Medical Group N.V. would violate federal antitrust law.
According to the complaint, which wasÌýfirst announced in November 2020,Ìýthe proposed acquisition would likely result in substantial competitive harm to consumers in the U.S. markets for total ankle replacements and finger joint implants.
Commission staff and the staff of the UK Competition and Markets Authority worked cooperatively to analyze the proposed transaction and potential remedies.
The final order requires Stryker and Wright to divest all assets associated with Stryker’s total ankle replacements and finger joint implants to DJO Global, allowing it to become an independent, viable, and effective competitor in these markets. The Commission vote to approve the final order was 5-0.
The Â鶹´«Ã½ Trade Commission works toÌýpromote competition, and protect and educate consumers. ÌýThe FTC will never demand money, make threats, tell you to transfer money, or promise you a prize. You can learn more aboutÌýhow competition benefits consumersÌýorÌýfile an antitrust complaint.ÌýÌýFor the latest news and resources,Ìýfollow the FTC on social media,Ìýsubscribe to press releasesÌýandÌýread our blog.